3317 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 14
00:21 UTC
|
WYFI
WhiteFiber
|
↑ Upgrade | Brett Knoblauch ★★☆☆☆ #2678 | Neutral→ Overweight | $27.00→ $36.00+33.3% |
|
Aug 14
00:21 UTC
|
WAY
Waystar
|
↑ Upgrade | firm only | Outperform | |
|
Aug 14
00:21 UTC
|
SPRB
Spruce Biosciences
|
↑ Upgrade | firm only | Overweight | |
|
Aug 14
00:21 UTC
|
SM
SM Energy
|
↑ Upgrade | Hanwen Chang ★★★☆☆ #1373 | Equal Weight→ Overweight | $32.00→ $47.00+46.9% |
|
Aug 14
00:21 UTC
|
SLGN
Silgan
|
↑ Upgrade | Arun Viswanathan ★★☆☆☆ #2355 | Sec→ r Perform ➝ Outperform | $51.00→ $58.00+13.7% |
|
Aug 14
00:21 UTC
|
SBSW
Sibanye Gold
|
↑ Upgrade | Ephrem Ravi ★★★☆☆ #1021 | Neutral→ Buy | $13.50 |
|
Aug 14
00:21 UTC
|
POR
Portland General Electric
|
↑ Upgrade | Paul Fremont ★★★☆☆ #1869 | Neutral→ Buy | $48.50 |
|
Aug 14
00:21 UTC
|
PHVS
Pharvaris
|
↑ Upgrade | firm only | Overweight | |
|
Aug 14
00:21 UTC
|
OGS
ONE Gas
|
↑ Upgrade | Paul Fremont ★★★☆☆ #1869 | Neutral→ Buy | $85.50 |
|
Aug 14
00:21 UTC
|
KDP
Keurig Dr Pepper
|
↑ Upgrade | Sorabh Daga not yet tracked | Hold→ Buy | $40.00 |
|
Aug 14
00:21 UTC
|
INO
Inovio Pharmaceuticals
|
↑ Upgrade | Roger Song ★★☆☆☆ #2568 | Hold→ Positive | $1.80→ $3.00+66.7% |
|
Aug 14
00:21 UTC
|
HYLN
Hyliion
|
↑ Upgrade | Ted Jackson ★★★☆☆ #1139 | Market Perform→ Outperform | $10.00 |
|
Aug 14
00:21 UTC
|
HLS
HLS Therapeutics
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Aug 14
00:21 UTC
|
FIVE
Five Below
|
↑ Upgrade | Randal Konik ★★☆☆☆ #2479 | Hold→ Buy | $210.00→ $350.00+66.7% |
|
Aug 14
00:21 UTC
|
FIVE
Five Below
|
↑ Upgrade | Randal Konik ★★☆☆☆ #2479 | Hold→ Buy | $350.00 |
|
Aug 14
00:21 UTC
|
FIVE
Five Below
|
↑ Upgrade | Paul Lejuez ★★☆☆☆ #2322 | Market Perform→ Buy | |
|
Aug 14
00:21 UTC
|
ESTA
Establishment Labs
|
↑ Upgrade | Joanne Wuensch ★★★★☆ #425 | Neutral→ Buy | $92.00 |
|
Aug 14
00:21 UTC
|
DOCS
Doximity
|
↑ Upgrade | firm only | Outperform | |
|
Aug 14
00:21 UTC
|
CLB
Core Laboratories
|
↑ Upgrade | firm only | Hold→ Buy | $21.00 |
|
Aug 14
00:21 UTC
|
CIB
Grupo Cibest
|
↑ Upgrade | firm only | Neutral→ Buy | |
|
Aug 14
00:21 UTC
|
CAVA
CAVA Group
|
↑ Upgrade | firm only | Sell→ Neutral | |
|
Aug 14
00:21 UTC
|
BRSL
Brightstar Lottery
|
↑ Upgrade | David Katz ★★★☆☆ #2207 | Hold→ Buy | $12.00→ $16.00+33.3% |
|
Aug 14
00:21 UTC
|
BIIB
Biogen
|
↑ Upgrade | Alexandria Hammond ★★★☆☆ #1631 | Peer Perform→ Outperform | $300.00 |
|
Aug 14
00:21 UTC
|
ANNX
Annexon
|
↑ Upgrade | Jonathan Wolleben ★★★★☆ #841 | Underperform→ Market Perform | |
|
Aug 14
00:21 UTC
|
AMX
America Movil
|
↑ Upgrade | firm only | Neutral→ Outperform | |
|
Aug 14
00:21 UTC
|
AKAM
Akamai Technologies
|
↑ Upgrade | Samik Chatterjee ★★★★☆ #785 | Underweight→ Neutral | $132.00→ $158.00+19.7% |
|
Aug 14
00:21 UTC
|
ABT
Abbott Laboratories
|
↑ Upgrade | Mike Polark not yet tracked | Peer Perform→ Outperform | $130.00 |
|
Aug 14
00:21 UTC
|
ABBV
AbbVie
|
↑ Upgrade | Alexandria Hammond ★★★☆☆ #1631 | Peer Perform→ Outperform | $300.00 |
|
Aug 13
20:20 UTC
|
FIVE
Five Below
|
↑ Upgrade | Randal Konik ★★☆☆☆ #2479 | Hold→ Buy | $210.00→ $350.00+66.7% |
|
Aug 13
19:20 UTC
|
SBSW
Sibanye Gold
|
↑ Upgrade | Ephrem Ravi ★★★☆☆ #1021 | Neutral→ Buy | $13.50 |
|
Aug 13
19:20 UTC
|
POR
Portland General Electric
|
↑ Upgrade | Paul Fremont ★★★☆☆ #1869 | Neutral→ Buy | $48.50 |
|
Aug 13
19:20 UTC
|
OGS
ONE Gas
|
↑ Upgrade | Paul Fremont ★★★☆☆ #1869 | Neutral→ Buy | $85.50 |
|
Aug 13
19:20 UTC
|
HLS
HLS Therapeutics
|
↑ Upgrade | firm only | Hold→ Buy | |
|
Aug 13
18:20 UTC
|
KDP
Keurig Dr Pepper
|
↑ Upgrade | Sorabh Daga not yet tracked | Hold→ Buy | $40.00 |
|
Aug 13
18:20 UTC
|
BIIB
Biogen
|
↑ Upgrade | Alexandria Hammond ★★★☆☆ #1631 | Peer Perform→ Outperform | $300.00 |
|
Aug 13
18:20 UTC
|
ABT
Abbott Laboratories
|
↑ Upgrade | Mike Polark not yet tracked | Peer Perform→ Outperform | $130.00 |
|
Aug 13
18:20 UTC
|
ABBV
AbbVie
|
↑ Upgrade | Alexandria Hammond ★★★☆☆ #1631 | Peer Perform→ Outperform | $300.00 |
|
Aug 13
17:20 UTC
|
INO
Inovio Pharmaceuticals
|
↑ Upgrade | Roger Song ★★☆☆☆ #2568 | Hold→ Positive | $1.80→ $3.00+66.7% |
|
Aug 13
17:20 UTC
|
BRSL
Brightstar Lottery
|
↑ Upgrade | David Katz ★★★☆☆ #2207 | Hold→ Buy | $12.00→ $16.00+33.3% |
|
Aug 13
15:19 UTC
|
SLGN
Silgan
|
↑ Upgrade | Arun Viswanathan ★★☆☆☆ #2355 | Sec→ r Perform ➝ Outperform | $51.00→ $58.00+13.7% |
|
Aug 13
15:19 UTC
|
FIVE
Five Below
|
↑ Upgrade | Paul Lejuez ★★☆☆☆ #2322 | Market Perform→ Buy | |
|
Aug 13
15:19 UTC
|
CLB
Core Laboratories
|
↑ Upgrade | firm only | Hold→ Buy | $21.00 |
|
Aug 13
15:19 UTC
|
CIB
Grupo Cibest
|
↑ Upgrade | firm only | Neutral→ Buy | |
|
Aug 13
15:19 UTC
|
AKAM
Akamai Technologies
|
↑ Upgrade | Samik Chatterjee ★★★★☆ #785 | Underweight→ Neutral | $132.00→ $158.00+19.7% |
|
Aug 13
14:19 UTC
|
FIVE
Five Below
|
↑ Upgrade | Randal Konik ★★☆☆☆ #2479 | Hold→ Buy | $350.00 |
|
Aug 13
13:19 UTC
|
SM
SM Energy
|
↑ Upgrade | Hanwen Chang ★★★☆☆ #1373 | Equal Weight→ Overweight | $32.00→ $47.00+46.9% |
|
Aug 13
13:19 UTC
|
SBSW
Sibanye Gold
|
↑ Upgrade | firm only | Neutral→ Buy | $13.50 |
|
Aug 13
13:19 UTC
|
POR
Portland General Electric
|
↑ Upgrade | firm only | Neutral→ Buy | $48.50 |
|
Aug 13
13:19 UTC
|
OGS
ONE Gas
|
↑ Upgrade | firm only | Neutral→ Buy | $85.50 |
|
Aug 13
13:19 UTC
|
KDP
Keurig Dr Pepper
|
↑ Upgrade | firm only | Hold→ Buy | $40.00 |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.